DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Rujun S, Yuyu H, Xikun S. et al.
Discussion on rational use of chinese patent medicine recommended from diagnosis and treatment protocols for COVID-19.
Chin J Mod Appl Pharm 2020;
37: 782-787
We do not assume any responsibility for the contents of the web pages of other providers.